BIT Biotech Opportunities S
WKN A3DCA9 | ISIN DE000A3DCA95 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | -3,12 % | +18,76 % | -0,29 |
|
| 2 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | -3,62 % | +19,58 % | -0,30 |
|
| 3 | LU1897414642 | Janus Henderson Horizon Biotechnology Fund E2 USD | -6,57 % | +27,59 % | -0,32 |
|
| 4 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -4,77 % | +20,45 % | -0,34 |
|
| 5 | LU1897414568 | Janus Henderson Horizon Biotechnology Fund IU2 USD | -7,34 % | +27,88 % | -0,34 |
|
| 79 | LU0415392249 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating | -12,22 % | +12,91 % | -1,12 |
|
| 80 | DE000A3DCA95 | BIT Biotech Opportunities S | -35,90 % | +30,91 % | -1,23 |
|
| 81 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -36,10 % | +30,90 % | -1,24 |
|
| 82 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -15,46 % | +13,82 % | -1,28 |
|
| 83 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -16,05 % | +13,82 % | -1,33 |
|